Bristol-Myers Squibb CEO talks $13 billion acquisition of heart drugs developer MyoKardia

Bristol-Myers Squibb CEO Giovanni Caforio joined Jim Cramer on "Mad Money" to discuss the deal for MyoKardia, which comes a year after the pharmaceutical company purchased Celgene.